Novo Nordisk's Ozempic and Wegovy now available in the U.S. after shortages, FDA says

It is a sign that Novo Nordisk's efforts to ramp up the supply of those drugs are starting to pay off, as demand continues to skyrocket in the U.S.

Read more at CNBC

Save story

Topics

Related

Ozempic and Wegovy considered 'available' after more than 2 years in shortage
Politics - The Hill - October 30
The Novo Nordisk scientist behind Ozempic, Wegovy weight loss research
Top stories - CBS News - November 4
Novo Nordisk shares jump 8% after Wegovy sales beat expectations
Business - CNBC - November 6
Novo Nordisk's Wegovy Sales Beat Expectations
Business - The Wall Street Journal - November 6
Novo Nordisk's diabetes drug Ozempic may reduce the risk of Alzheimer's disease, study says
Business - CNBC - October 24
Novo Nordisk Launches Wegovy Weight-Loss Drug in China
Business - The Wall Street Journal - 3 days ago
Ozempic maker Novo Nordisk nudges higher profit forecast
Business - MarketWatch - November 6

More from CNBC

Donald Trump chooses hedge fund executive Scott Bessent for Treasury secretary
Business - CNBC - 7 hours ago
'I have no money': Thousands of Americans see their savings vanish in Synapse fintech crisis
Business - CNBC - 13 hours ago
Why X's new terms of service are driving some users to leave Elon Musk's platform
Business - CNBC - 15 hours ago
Amazon to invest another $4 billion in Anthropic, OpenAI's biggest rival
Business - CNBC - 16 hours ago
Student loan legal battles delay SAVE borrowers' path to forgiveness
Business - CNBC - 13 hours ago